Luis Lopez

Dr. Luis Lopez

Biomedical Research Center, Institute of Biotechnology, University of Granada, Granada, Spain
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2014 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
Dario Acuña-CastroviejoDario Acuña-Castroviejo
Dario Acuña-Castroviejo
Germaine EscamesGermaine Escames
Germaine Escames
CVCarmen Venegas
Carmen Venegas
MDM. Elena Díaz-Casado
M. Elena Díaz-Casado
ECElena Lima Cabello
Elena Lima Cabello
RRRussel J. Reiter
Russel J. Reiter

2 September 2011 in Journal of Pineal Research
Verified
Journal Article
Closed access
CVCarmen Venegas
Carmen Venegas
JGJosé A. García
José A. García
Germaine EscamesGermaine Escames
Germaine Escames
FOFrancisco Ortiz
Francisco Ortiz
ALAna López
Ana López
Dario Acuña-CastroviejoDario Acuña-Castroviejo
Dario Acuña-Castroviejo

1 December 2006 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
Luis LopezLuis Lopez
Luis Lopez
MSMarkus Schuelke
Markus Schuelke
CQCatarina M. Quinzii
Catarina M. Quinzii
Tomotake KankiTomotake Kanki
Tomotake Kanki
RRRichard Rodenburg
Richard Rodenburg
MHMichio Hirano
Michio Hirano

1 March 2008 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
CLClotilde Lagier-Tourenne
Clotilde Lagier-Tourenne
MTMeriem Tazir
Meriem Tazir
Luis LopezLuis Lopez
Luis Lopez
CQCatarina M. Quinzii
Catarina M. Quinzii
MAMirna Assoum
Mirna Assoum
MKMichel Koenig
Michel Koenig

29 January 2009 in Journal of Pineal Research
Verified
Journal Article
Closed access
PDF file
ALAna López
Ana López
JGJosé A. García
José A. García
Germaine EscamesGermaine Escames
Germaine Escames
CVCarmen Venegas
Carmen Venegas
FOFrancisco Ortiz
Francisco Ortiz
Dario Acuña-CastroviejoDario Acuña-Castroviejo
Dario Acuña-Castroviejo

1 January 2011 in Current Topics in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
Dario Acuña-CastroviejoDario Acuña-Castroviejo
Dario Acuña-Castroviejo
Luis LopezLuis Lopez
Luis Lopez
Germaine EscamesGermaine Escames
Germaine Escames
ALAna Lopez
Ana Lopez
JGJose A. Garcia
Jose A. Garcia
RRRussel J. Reiter
Russel J. Reiter
Although two main hypotheses of mitochondrial origin have been proposed, i.e., the autogenous and the endosymbiotic, only the second is being seriously considered currently. The ‘hydrogen hypothesis’ invokes metabolic symbiosis as the driving force for a symbiotic association between an anaerobic, strictly hydrogen-dependent (the host) and an eubacterium (the symbiont) that was able to respire, but which generated molecular hydrogen as an end product of anaerobic metabolism. The resulting proto-eukaryotic cell would have acquired the essentials of eukaryotic energy metabolism, evolving not only aerobic respiration, but also the physiological cost of the oxygen consumption, i.e., generation of reactive oxygen species (ROS) and the associated oxidative damage. This is not the only price to pay for respiring oxygen: mitochondria possess nitric oxide (NO • ) for regulatory purposes but, in some instances it may react with superoxide anion radical to produce the toxic reactive nitrogen species (RNS), i.e. peroxynitrite anion, and the subsequent nitrosative damage. New mitochondria contain their own genome with a modified genetic code that is highly conserved among mammals. The transcription of certain mitochondrial genes may depend on the redox potential of the mitochondrial membrane. Mitochondria are related to the life and death of cells. They are involved in energy production and conservation, having an uncoupling mechanism to produce heat instead of ATP, but they are also involved in programmed cell death. Increasing evidence suggest the participation of mitochondria in neurodegenerative and neuromuscular diseases involving alterations in both nuclear (nDNA) and mitochondrial (mtDNA) DNA. Melatonin is a known powerful antioxidant and antiinflammatory and increasing experimental and clinical evidence shows its beneficial effects against oxidative/nitrosative stress status, including that involving mitochondrial dysfunction. This review summarizes the data and mechanisms of action of melatonin in relation to mitochondrial pathologies.